about
Interventions for actinic keratosesInterventions for actinic keratosesTreatment of common warts and actinic keratoses by Er:YAG laser.Pharmacotherapy of actinic keratosis.Case-based experience in the use of 5-fluorouracil cream 0.5% as monotherapy and in conjunction with glycolic acid peels for the treatment of actinic keratosis.Safety and Efficacy of Multiple 16-week Courses of Topical Imiquimod for the Treatment of Large Areas of Skin Involved with Actinic KeratosesConsiderations for use of Fluorouracil cream 0.5% for the treatment of actinic keratosis in elderly patientsPharmacotherapy of actinic keratosis: an update.Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses.Levulan: the first approved topical photosensitizer for the treatment of actinic keratosis.Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.Actinic keratosis: the key event in the evolution from photoaged skin to squamous cell carcinoma. Therapy based on pathogenetic and clinical aspects.New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel.In-office Painless Aminolevulinic Acid Photodynamic Therapy: A Proof of Concept Study and Clinical Experience in More Than 100 PatientsSolar keratosis: epidemiology, pathogenesis, presentation and treatment.Actinic keratosis: an occupational and environmental disorder.Comparison of topical 5-fluorouracil formulations in actinic keratosis treatment.Diclofenac gel in the treatment of actinic keratoses.A review of actinic keratosis for the nurse practitioner: diagnosis, treatment, and clinical pearls.Update on non-melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring.A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.Nanovesicular carrier-based formulation for skin cancer targeting: evaluation of cytotoxicity, intracellular uptake, and preclinical anticancer activity.Long-term Follow up of Diclofenac Sodium 3% in 2.5% Hyaluronic Acid Gel for Actinic Keratosis: One-year Evaluation.Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel.A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study.Actinic keratosis treated with an immune response modifier: a case report of six patients.Treatment of actinic keratoses on the dorsum of the hands: ALA-PDT versus diclofenac 3% gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study.Efficacy of imiquimod as an adjunct to cryotherapy for actinic keratoses.Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.
P2860
Q24202407-F063B11C-B244-4482-8D20-074674C90A87Q24247792-458A0786-4A4F-41C4-B9B6-8DD91583E62DQ30800042-B6E7B34B-71A5-482B-A8B6-B893802CCA5EQ30898080-530B168C-B4D0-4A39-8F62-61057D78F272Q33525146-49E14538-9CC8-42CC-9236-C2D4EC17CD65Q34074154-DB9CD88F-22E6-46E8-B2B6-2367E5A44ECEQ34340855-CCE2A445-9208-4B4D-B852-71049E03C08DQ34378153-5B77E479-D06A-4C28-A188-1DFD0F747F81Q34519798-7DAE8C3F-C821-4DA6-9E2F-4831B5968D87Q34680979-3B8163ED-63C1-41A0-A229-E776441A8B21Q34761817-9450C917-CFC4-4B35-8907-4DB375E10CDDQ35672075-2A5D3E83-C9BE-448F-89F2-80506F7AF0DFQ36196699-E122CB24-5E8B-4C4D-BE7B-0AC885824729Q36631465-60C45772-3453-445A-8BA7-259E24081030Q36834360-F0E3E7C3-9E46-4D86-89E1-2BB7F92C47CBQ37138061-767F6B54-6D9C-45D9-A0AC-FC76FCF0DC8DQ37624773-895F1928-FCC0-4718-A730-6433AC9FA0D0Q37900834-C36F153C-5EFA-40C5-9B29-44AA1E3909D1Q38007015-F6C6CBA1-9DF6-4FA2-8BB6-E5C3FB05021DQ38101606-4E3E5884-930F-4BCE-BB51-4C1DC37D1E40Q38423180-6F73C607-ED39-4D31-BEAF-F4942B5EC4BCQ38938396-B07E607C-5612-4C4C-8D30-862232F6978BQ42155148-9B8B340B-D42D-4E54-90BD-FA43FF307866Q43612584-4160B70E-9395-41F8-904E-6B2356FED7E6Q43883684-94920902-B101-48C5-82A8-3AED89CAB54FQ44458997-DBE14333-6BC1-4C95-9EA9-4C554B46A29DQ44655284-C07DE695-5573-4993-88D1-50EBF705B678Q46049367-EA87A834-92EC-4B32-B3A1-F34647C7437CQ46879683-C0FE4CBC-F0E3-49CE-AD31-6A56338F0638Q53223317-B62EAFA6-5847-4615-9378-F14970EA1089
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The treatment of actinic keratoses.
@ast
The treatment of actinic keratoses.
@en
type
label
The treatment of actinic keratoses.
@ast
The treatment of actinic keratoses.
@en
prefLabel
The treatment of actinic keratoses.
@ast
The treatment of actinic keratoses.
@en
P356
P1476
The treatment of actinic keratoses.
@en
P2093
Dinehart SM
P356
10.1067/MJD.2000.103338
P407
P433
P577
2000-01-01T00:00:00Z